Description

Eterna Peptides presents premium-grade Tesamorelin lyophilized powder, an elite synthetic peptide analogue of endogenous Growth Hormone-Releasing Hormone (GHRH). Composed of a stabilized 44-amino-acid sequence, Tesamorelin features a custom-engineered hexenoyl group attached to its N-terminal tyrosine residue. This structural modification significantly resists enzymatic degradation by dipeptidyl peptidase-4 (DPP-4), exponentially extending its experimental half-life compared to native GHRH. Available in 10mg and 20mg standalone single-vial mass configurations, this premium compound serves as an elite investigative tool for tracking pituitary somatotroph stimulation, targeted visceral adiposity reduction, and growth hormone axis modeling.

### Available Research Configurations
* **Tesamorelin 10mg Vial:** Standardized for exploratory baseline protocols, short-duration cellular assays, and lipid profile screening.
* **Tesamorelin 20mg Vial:** High-capacity presentation calibrated for intensive dose-response tracking and extended multi-subject longitudinal tissue modeling.

### Mechanism of Action
Tesamorelin operates as a selective metabolic modulator via highly specific neuroendocrine pathways:
* **Pituitary Somatotroph Activation:** Tesamorelin binds with high affinity to GHRH receptors on somatotroph cells in the anterior pituitary gland. This binding triggers a cyclic adenosine monophosphate ($cAMP$) signaling cascade, driving the pulsatile synthesis and systemic secretion of endogenous Growth Hormone ($GH$).
* **Hepatic IGF-1 Transcription:** Enhanced circulating GH waves signal the liver to increase the transcription and secretion of Insulin-like Growth Factor-1 ($IGF\text{-}1$). This downstream growth factor amplification supports cellular protein synthesis and lean tissue matrix maintenance.
* **Visceral Lipolysis Signaling:** Tesamorelin is intensively investigated for its unique lipolytic action. It effectively targets and mobilizes deep visceral adipose tissue (VAT) by modulating lipolytic enzyme expression, while notably avoiding the disruption of subcutaneous fat deposits or altering basic glucose baseline dynamics.
* **Preservation of Natural Feedback Loops:** Unlike synthetic growth hormone administration which can cause receptor shutdown, Tesamorelin maintains intact negative feedback regulations via somatostatin, making it a valuable tool for tracking natural somatotropic axes.

### Research Applications
In preclinical and in vitro laboratory models, Tesamorelin vials are actively utilized to investigate:
* High-velocity visceral fat reduction, lipolysis kinetics, and metabolic rate repartitioning.
* Musculoskeletal structural remodeling, lean skeletal muscle mass retention, and connective tissue recovery.
* Pituitary GHRH receptor saturation metrics and enzymatic DPP-4 degradation resistance curves.
* Chronological longevity indicators, cellular senescence delays, and age-related growth hormone decline modeling.

Our Tesamorelin vials undergo strict laboratory stabilization, high-grade purification, and uniform vacuum-drying guidelines to ensure absolute peptide chain integrity, rapid reconstitution kinetics, and dependable experimental reproducibility.

—
*Disclaimer: This product is sold strictly for laboratory research and development use only. It is not intended for human consumption, diagnostic, or therapeutic purposes.*